U.S. Industrials Stock News

In the past quarter, Collegium Pharmaceutical reported a strong Q3, with revenue rising 31.4% year on year and topping analyst expectations by 10.7%, driven by its differentiated pain management medicines. The company also exceeded its full-year revenue guidance, signaling operational strength that reinforces its focus on specialty products for chronic pain. With Q3 revenue surpassing expectations by 10.7%, we’ll now examine how this performance influences Collegium’s existing investment...

Wondering if Exxon Mobil is still a buy after its huge run over the last few years, or if the easy money has already been made? You are not alone. Despite a 240.2% gain over 5 years and a solid 10.1% return over the last year, the stock has cooled recently, slipping 3.0% over the past week and 3.9% over the last month, while still up 6.9% year to date. Recent moves have been shaped by shifting expectations for long term oil and gas demand and renewed focus on energy security, as markets...

Wondering if Huntington Ingalls Industries is still a smart buy after its big run, or if the market has already priced in the upside? This breakdown will walk through what the current share price really implies. The stock has climbed to around $326.80, with gains of 3.8% over the last week, 4.1% over the last month, and 74.2% year to date, building on a 72.9% 1-year return and 123.6% over 5 years that has clearly shifted how investors see its prospects and risks. That re-rating has been...

Crocs (CROX) has quietly staged a comeback, with shares up roughly 25% over the past month and about 14% in the past 3 months, despite flat revenue and volatile long term returns. See our latest analysis for Crocs. Zooming out, that strong 1 month share price return contrasts with a negative year to date share price return and a weak 1 year total shareholder return, hinting that sentiment may be turning after a choppy stretch. If Crocs has you rethinking where growth might show up next in...

If you are wondering whether Centene is a beaten down bargain or a value trap at current prices, this article will walk through what the numbers are really saying about the stock. Despite being down 35.6% year to date and 32.6% over the past year, the share price has shown some recent stability, with a 2.3% gain over the last week and 7.1% over the last month. Much of the recent price action has been shaped by shifting expectations around US healthcare policy and Medicaid redeterminations,...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

The board of The Toro Company ( NYSE:TTC ) has announced that it will be paying its dividend of $0.39 on the 12th of...

Some CME Group Inc. ( NASDAQ:CME ) shareholders may be a little concerned to see that the Chairman & CEO, Terrence...

Some The Carlyle Group Inc. ( NASDAQ:CG ) shareholders may be a little concerned to see that the Co-Founder...

Wondering if monday.com is starting to look like a bargain after its slide, or if the market is signaling deeper concerns about the business. The stock is down 7.6% over the last week, 6.5% over the past month, and a steep 35.0% year to date, extending a 40.4% drop over the last year despite still being up 29.5% over three years. Much of this volatility has been driven by shifting sentiment toward high growth software names as interest rate expectations change, with investors rotating in and...

HCI Group recently reported that its core homeowners insurance operations have grown rapidly over the past two years, with net premiums earned rising about 28% annually as it applies proprietary technology to underwriting and claims. Analysts now expect book value per share to increase by about 36.9% over the coming 12 months, highlighting how HCI’s capital generation and balance sheet strength are being reinforced by this operating momentum. We’ll now consider how this acceleration in net...

Morgan Stanley previously downgraded HCA Healthcare from Equalweight to Underweight, and HCA later announced a senior notes offering to help refinance borrowings and support general corporate needs. A large institutional holder, L1 Capital International Fund, has also reduced its position after strong share price appreciation, signalling a reassessment of risk‑reward at current levels. Next, we’ll examine how concerns about potentially easing government healthcare tailwinds could reshape HCA...

If you are wondering whether Symbotic is still worth considering after its huge run, or if you are late to the party, this breakdown will help you figure out what the current price is really asking you to believe. The stock has climbed about 0.8% over the last week and 7.8% over the last month, but the real eye catchers are its 153.7% year to date and 145.6% 1 year returns, on top of a 408.8% gain over 3 years. Recent headlines have focused on Symbotic's expanding automation partnerships and...

Wondering if Hecla Mining is still a bargain after its huge run, or if you are turning up late to the party? This breakdown will help you make sense of what the current share price really implies. The stock has surged recently, climbing 11.9% over the last week, 30.3% over the past month, and an eye catching 261.6% year to date. This has completely changed how the market is thinking about its risk and reward profile. That kind of move has been underpinned by a stronger silver price backdrop...

Canaan (NasdaqGM:CAN) has been quietly grinding through a tough stretch, with the stock down sharply this year even as annual revenue and net income growth have swung higher off a low base. See our latest analysis for Canaan. Still, the 1 year to date share price return of negative 64.23 percent and 1 year total shareholder return of negative 73.27 percent show that sentiment has been deteriorating rather than stabilising, as investors continue to price in execution and crypto cycle risks. If...

Shopify (SHOP) has quietly kept climbing, with shares up about 12% over the past month and more than 50% year to date, as investors lean into its accelerating revenue and profit growth. See our latest analysis for Shopify. That latest leg higher takes Shopify’s share price to about 163 dollars, and with a roughly 12 percent 1 month share price return and 3 year total shareholder return above 350 percent, the trend still points to strong, long term momentum rather than a fading spike. If...

If you are wondering whether StoneCo is still a recovery story or already a bargain hiding in plain sight, this breakdown will help you assess whether the current price makes sense. Despite a choppy near term, with the stock roughly flat over the last week and down about 12.5% in the last month, StoneCo is still up 81.1% year to date and 68.4% over the past year, a sharp swing from its deeply negative 5 year return. Recent share price moves have been driven by shifting sentiment around...

Earlier in December 2025, Flagstar Private Bank and Wealth Management expanded its Private Client and Wealth business, launching new Family Advisory, Trusts and Estate Planning, and Insurance capabilities while rolling out a three-region model and sector-focused verticals backed by senior hires from major global banks. This build-out signals an effort to become a more comprehensive private banking platform for high-net-worth clients in key markets like New York, Florida, and...

Anyone interested in Cogent Communications Holdings, Inc. ( NASDAQ:CCOI ) should probably be aware that the VP, CFO...

Wondering if Nucor is still a good buy after its run up, or if you have missed the moment? This breakdown will help you decide whether the current price really stacks up against its fundamentals. The stock has climbed 2.6% over the last week, 9.8% over the past month, and is up 41.7% year to date after a 36.5% gain over the last year. This has put it firmly on the radar of both value and momentum investors. Recent moves have been driven by a mix of optimism around US infrastructure and...

Unfortunately for some shareholders, the Wheels Up Experience Inc. ( NYSE:UP ) share price has dived 36% in the last...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...

Graham Holdings (GHC) has been quietly rewarding patient investors, with the stock up about 28% this year and more than doubling over the past 3 years, despite relatively modest recent revenue growth. See our latest analysis for Graham Holdings. At around $1,108.82 per share, Graham Holdings has cooled slightly in the very short term, but its strong year to date share price return and hefty three year total shareholder return suggest momentum is still firmly on the side of long term...

Kestra Medical Technologies (KMTS) has been quietly grinding higher, with the stock up around 2% on the day, nearly 9% over the past week, and roughly 24% year to date. See our latest analysis for Kestra Medical Technologies. That kind of steady climb in the share price, capped by a 1 day share price return of just under 2 percent, suggests momentum is building as investors warm to Kestra Medical Technologies growth story and reassess its risk profile. If this move in Kestra Medical...